Impact Of FDA Advisory Cmte. Conflict Rules Extends To OTC Side
Executive Summary
New Nonprescription Drugs Advisory Committee member James Kehrer's expertise in acetaminophen toxicity should make him a key figure at FDA's upcoming meeting on the drug, he says